![Mark Kafka](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Mark Kafka worked at Genentech, Inc. as Senior Director & Associate General Counsel.
Mr. Kafka worked at Denali Therapeutics, Inc. as Vice President-IP, Transactions & Legal from 2022 to 2026.
Mr. Kafka graduated from the University of California San Diego and the University of San Diego School of Law.
Eerdere bekende functies van Mark Kafka
| Bedrijven | Functie | Einde |
|---|---|---|
| DENALI THERAPEUTICS INC. | Algemeen Adviseur | 01-02-2026 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur/Bestuurslid | - |
Opleiding van Mark Kafka
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
5
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of San Diego School of Law
 University of San Diego School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Denali Therapeutics, Inc.
 Denali Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutics for neurodegenerative diseases | Health Technology |
